Through successful partnerships we have built a truly leading global biopharmaceutical development specialist. Our people provide the passion and inspiration to bring important new medicines to market; our marketed products provide us with the financial resources to maintain a robust pipeline of promising drug candidates and our partners provide new discoveries that fuel our pipeline with innovative new biologic and small molecule medicines.

Since 1979, our drug development experience, project management expertise and financial strength have enabled us to take full responsibility for product development through to regulatory approval. Because of our unique size and private status, we are able to pursue a wide variety of projects and establish partnerships where our interests are closely shared.

We have now built a team of 300 people and a vast international network of external experts that can support 10 clinical products in development in our pipeline each year. Our team’s objective is to bring innovative drugs to the market rapidly, through a focused and multidisciplinary approach, capitalising on the experience, creativity and intelligence of our staff and network.

We strongly believe that success comes not only from our technical expertise, but also from the perseverance of our team, their motivation and their enthusiasm.

Social Corporate Responsibility is an important part of our mission. To contribute to the health of our planet, we continually review and improve our efforts to reduce the burden on our environment. It is my wish that we build our scientific and business decisions on actions geared towards sustainable development, including social, environmental and economical issues. 

We are looking to be your partner of choice, taking on full financial and managerial responsibility for your entire project, while sharing in the success together.

Dr Rolland-Yves Mauvernay
President & Founder